BusinessWire

DALLAS--(BUSINESS WIRE)--Flowserve Corporation (NYSE: FLS), a leading provider of flow control
products and services for the global infrastructure markets, today
announced that it plans to release its financial results for the 2017
third quarter after the close of the New York Stock Exchange (NYSE) on
Wednesday, November 1, 2017.


New affiliation between AIDS Outreach Center (AOC) and AIDS
Healthcare Foundation (AHF) seeks to improve delivery of prevention and
lifesaving HIV/AIDS care and services in eight North Texas counties

Focused on the digitization of transportation, the companies
reinforce their collaboration and take first step toward transitioning
from manual to automated trains

REDONDO BEACH, Calif.--(BUSINESS WIRE)--Leonardo247 is pleased to announce that Greystar, a global leader in the
investment, development and management of rental housing, will rollout
Leonardo247’s automated performance management solution across its
entire U.S. portfolio of multifamily properties.


Recognition Follows Success On and Off the Course In 2017, as the
Brand Unveils 2018 GO GOLF Footwear Collection.

The 21st annual event, presented by Staples, raises funds to benefit
women everywhere


BUENOS AIRES, Argentina--(BUSINESS WIRE)--Despegar.com, Corp. (NYSE:DESP), the leading online travel company in
Latin America, today announced that it will report its Third Quarter
2017 results on Thursday, November 16, after the market closes.

Earnings Release

Thursday, November 16, 2017

Strengthens Cint’s reach in LATAM with new, local audience of more
than 500,000

PEMBROKE, Bermuda & ZURICH--(BUSINESS WIRE)--AXIS Capital Holdings Limited (“AXIS Capital”) (NYSE:AXS) announced
today that Steve Arora has been named Chief Executive Officer of AXIS
Re. Mr. Arora joins the Company from Swiss Re where he spent 18 years in
a variety of senior positions, most recently as Head of Casualty
Reinsurance and as a member of the Reinsurance Executive Committee. He
has extensive international experience and leadership capabilities and

Near-term Priorities Include GlucoTrack Commercialization in
Europe and GlucoTrack US FDA Approval

Pages